血管紧张素转换酶抑制剂联合钙离子通道阻滞剂在高血压治疗中的应用进展  

Advancements in Angiotensin Converting Enzyme Inhibitor Combined with Calcium Channel Blocker in Treatment of Hypertension

作　　者：徐少东[1] 施有为[1] 张君良[1] 

机构地区：[1]合肥市第一人民医院心内科,安徽合肥230001

出　　处：《心血管病学进展》2009年第4期569-572,共4页Advances in Cardiovascular Diseases

摘　　要：高血压是一种临床常见的心血管综合征,由于其发病机制复杂,单药治疗血压控制达标率低,而联合治疗通过干预多种升压机制,不仅使血压控制达标率明显增高,而且具有良好的靶器官保护作用。研究表明在众多联合治疗方案中血管紧张素转换酶抑制剂联合钙离子通道阻滞剂可能是最优化的一种,现将对此进行综述。Hypertension is a common clinical cardiovascular syndrome. Due to its complex pathogenesis, the ability to control blood pressure with single-drug treatment is low. However, the combination of different antihypertensive drugs not only controls blood pressure better, but also provides target organ protection. Research shows that the treatment of hypertension using the angiotensin converting enzyme inhibitor, combined with calcium channel blockers may be an optimal combination. This article reviews the use of this combination in the treatment of hypertention.

关 键 词：高血压 血管紧张素转换酶抑制剂 钙离子通道阻滞剂 联合 

分 类 号：R544.1[医药卫生—心血管疾病]